Point72 (DIFC)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.75M Buy
+35,400
New +$6.28M 0.44% 62
2024
Q3
Sell
-15,568
Closed -$2.13M 1543
2024
Q2
$2.13M Buy
+15,568
New +$2.13M 0.08% 318

Other funds holding DGX

Point72 (DIFC)'s DGX Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Quest Diagnostics (DGX) in Q3 2025: 35,400 shares worth $6.75M. The stake represents 0.44% of the portfolio and ranks #62 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in DGX as recently as Q2 2024.

Point72 (DIFC) first reported a position in DGX in Q2 2024 and has held it in 2 quarters since. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Point72 (DIFC) held 35,400 shares of Quest Diagnostics worth $6.75M as of Q3 2025.
  • Quest Diagnostics was a new Point72 (DIFC) position in Q3 2025.
  • Quest Diagnostics made up 0.44% of Point72 (DIFC)'s portfolio in Q3 2025, its #62 holding.
  • Point72 (DIFC) first reported a position in Quest Diagnostics in Q2 2024 and has held it in 2 quarters since.
  • 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.